AllianceBernstein’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82M | Buy |
1,536,200
+284,831
| +23% | +$15.2M | 0.03% | 461 |
|
|
2025
Q1 | $50.7M | Sell |
1,251,369
-587,912
| -32% | -$23.8M | 0.02% | 584 |
|
|
2024
Q4 | $51.2M | Sell |
1,839,281
-177,807
| -9% | -$4.95M | 0.02% | 587 |
|
|
2024
Q3 | $57.9M | Buy |
2,017,088
+109,231
| +6% | +$3.13M | 0.02% | 567 |
|
|
2024
Q2 | $44.8M | Buy |
1,907,857
+286,595
| +18% | +$6.72M | 0.02% | 626 |
|
|
2024
Q1 | $41M | Buy |
1,621,262
+13,571
| +0.8% | +$343K | 0.01% | 660 |
|
|
2023
Q4 | $37.5M | Buy |
1,607,691
+325,981
| +25% | +$7.61M | 0.01% | 675 |
|
|
2023
Q3 | $64.8M | Buy |
1,281,710
+1,161,305
| +964% | +$58.7M | 0.03% | 484 |
|
|
2023
Q2 | $5.62M | Buy |
120,405
+46,515
| +63% | +$2.17M | ﹤0.01% | 1386 |
|
|
2023
Q1 | $2.83M | Buy |
73,890
+39,310
| +114% | +$1.5M | ﹤0.01% | 1682 |
|
|
2022
Q4 | $1.89M | Buy |
34,580
+10,052
| +41% | +$551K | ﹤0.01% | 1950 |
|
|
2022
Q3 | $835K | Buy |
24,528
+3,128
| +15% | +$106K | ﹤0.01% | 2386 |
|
|
2022
Q2 | $202K | Buy |
21,400
+5,400
| +34% | +$51K | ﹤0.01% | 3019 |
|
|
2022
Q1 | $227K | Hold |
16,000
| – | – | ﹤0.01% | 2951 |
|
|
2021
Q4 | $338K | Hold |
16,000
| – | – | ﹤0.01% | 2900 |
|
|
2021
Q3 | $358K | Sell |
16,000
-2,900
| -15% | -$64.9K | ﹤0.01% | 2886 |
|
|
2021
Q2 | $469K | Buy |
18,900
+4,200
| +29% | +$104K | ﹤0.01% | 2827 |
|
|
2021
Q1 | $426K | Sell |
14,700
-2,300
| -14% | -$66.7K | ﹤0.01% | 2720 |
|
|
2020
Q4 | $439K | Sell |
17,000
-1,700
| -9% | -$43.9K | ﹤0.01% | 2643 |
|
|
2020
Q3 | $576K | Sell |
18,700
-3,400
| -15% | -$105K | ﹤0.01% | 2453 |
|
|
2020
Q2 | $551K | Buy |
22,100
+7,900
| +56% | +$197K | ﹤0.01% | 2536 |
|
|
2020
Q1 | $301K | Buy |
+14,200
| New | +$301K | ﹤0.01% | 2610 |
|